Kantonsspital St.Gallen

A phase III trial of marizomib in combination with standard

Dagmar Hess

abstract Phase 1/2 Open-label Trial of Tinostamustine Conditioning and Autologous Stem Cell Transplantation for Salvage Treatment in Relapsed / Refractory Multiple Myeloma (TITANIUM 1)
type of project clinical studies
status scheduled
start of project 2019
end of project 2019
study design Phase 1/2
responsible person Dr. med. Dagmar Hess